Experimental investigation of hypolipidemic and anti-atherosclerotic drugs with different mechanism of action.
D000818:Animals; D001161:Arteriosclerosis / Q000517:prevention & control*; D002219:Carbamates / Q000627:therapeutic use*; D002784:Cholesterol / Q000096:biosynthesis; D002807:Chondroitin / Q000031:analogs & derivatives*; D002809:Chondroitin Sulfates / Q000494:pharmacology / Q000627:therapeutic use*; D006224:Cricetinae; D006168:Guinea Pigs; D000960:Hypolipidemic Agents / Q000494:pharmacology / Q000627:therapeutic use; D008099:Liver / Q000378:metabolism; D051379:Mice; D010421:Pentanoic Acids / Q000494:pharmacology*; D011720:Pyrazoles / Q000627:therapeutic use*; D011727:Pyridinolcarbamate / Q000627:therapeutic use*; D011817:Rabbits; D051381:Rats; D014631:Valerates / Q000494:pharmacology*
D002219:Carbamates; D000960:Hypolipidemic Agents; D010421:Pentanoic Acids; D011720:Pyrazoles; D014631:Valerates; D011727:Pyridinolcarbamate; D002807:Chondroitin; D002809:Chondroitin Sulfates; D002784:Cholesterol